NervGen Pharma financials at a glance
| Year | Year | 2019 | 2020 | 2018 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M | C$0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
C$-0.32 | C$-0.39 | C$-0.38 | C$0.00 | |||
| Div. | Dividends |
|
C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 | C$0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
29.35m | 35.12m | 0m | 35.5m | 46.27m | 0m | 59.73m |
| OCF | Operating Cash Flow |
|
C$-8.09M | C$-6.31M | C$-1.04M | C$-8.27M | C$-17.78M | C$-11.30M | C$0.00M |
| FCF | Free Cash Flow |
|
C$0.00M | C$0.00M | C$0.00M | C$-8.27M | C$-17.81M | C$-11.31M | C$0.00M |
| FCFS | Free Cash Flow Per Share |
|
C$-0.31 | C$-0.20 | C$-0.14 | C$-0.21 | C$-0.34 | C$-0.19 | C$0.00 |